Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether HealthEquity and certain of its officers and/or ...

Such investors are advised to contact Danielle Peyton at ... or 646-581-9980, ext. 7980. The investigation concerns whether HealthEquity and certain of its officers and/or directors have engaged ...

Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised ...

Investors and stakeholders in HealthEquity will be watching closely ... by $17 million in additional service costs related to fraud issues, which have been a significant challenge for the company.